HaitiDocs

Data / Partner portfolio / UN agencies' core resources / World Health Organization

Mitigate the risk of the emergence and re-emergence of high-threat pathogens

Published title: Mitigate the risk of the emergence and re-emergence of high-threat pathogens and improve pandemic preparedness

US$ millions unless stated. Haitian fiscal year, October to September. FY2026-27 began October 1, 2026.

Description

The Secretariat will step up its leadership by: establishing, leading, managing and strengthening the technical networks and global partnerships for research, development and allocation of countermeasures, as well as for the prevention, control and mitigation of novel, high-threat infectious hazards; developing global strategies, with regional specificities, guidance and tools to prevent and manage emerging or re-emerging high-threat pathogens; strengthening the implementation of the Pandemic Influenza Preparedness Framework, and coordinating the Global Influenza Surveillance and Response System; developing plans, strategies, systems and tools for epidemic and pandemic disease preparedness, such as the Preparedness and Resilience for Emerging Threats initiative; and strengthening pandemic preparedness, engaging multisectoral partnerships, with communities at the centre. The Secretariat will support countries to: prepare, prevent and manage

more

outbreaks of emerging or re-emerging high-threat pathogens, and scale up interventions based on context and transmission patterns. This support will include the revision of pandemic preparedness plans taking into account specific and unknown (disease X) pathogens; develop and implement robust IPC strategies at the national level to ensure that core components, including personal protective equipment, are adequate and available; better understand community beliefs and behaviours in order to successfully implement community engagement activities in mitigating and managing outbreaks of high-risk pathogens; implement the Global influenza strategy 2019?2030 in order to strengthen detection of emerging influenza viruses, scale up national sustainable influenza programmes and develop new tools for disease prevention and control; and strengthen national capacity to guarantee the safe and secure retention of polioviruses, in line with the global action plan for poliovirus containment (GAPIII), and ensure that facilities that retain polioviruses are fully certified, as outlined in the containment certification scheme. In producing technical products on norms/standard, data and research, the Secretariat will: produce standard protocols, guidance and control strategies to prevent, manage, and reduce the health and security impacts of emerging and re-emerging pathogens and biosecurity hazards, including respiratory pathogens and vector-borne diseases; produce pandemic preparedness plans for unknown diseases (disease X), and guidelines and strategies for accelerating research on emerging pathogens; produce collaboratively evidence-based pandemic influenza preparedness packages, including guidance, standard operating procedures, training materials and platforms and continue to provide global influenza vaccine strain recommendations to inform the composition of the seasonal (or pandemic) influenza vaccine; and operationalize the WHO Advisory Committee on Variola Virus Research, and oversee the biosecurity inspections of the two global repositories of variola virus where the last remaining stocks of live variola virus have been held since the eradication of smallpox.

Partner
UN agencies' core resources, World Health Organization
Sector
Health
Stage
Closed since December 31, 2025
Approval
January 1, 2024
Closing
December 31, 2025
Disbursed as of
Not reported
Implementing agency
Not reported
Effectiveness
Not reported
Departments
Ouest
Last transaction
January 1, 2024
Operation ID
core:IATI:XM-DAC-928-HT-2024-25-02.002.AM01.HTI03

Financing

Table 1.Position at the data date by source (stocks), US$ millions

This pageSource
CommitmentNot reported
DisbursedNot reported
UndisbursedThe balance each partner reports as not yet disbursed, summed only when every operation in scope reports it.Not reported
Total costNot reported

IATI amounts. Approved: The commitments the partner reports, converted to US$. Disbursed to date: The disbursements (IATI transaction type 3, funds paid to another organization) and expenditure (type 4, funds spent by the publisher) the partner reports, converted to US$. Undisbursed: The undisbursed balance the record gives, where the partner reports one, in US$. Amounts by source

Changes to the operationnot reported
Original closing date
Not reported
Closing date extensions
Not reported
Restructurings
Not reported
Emergency component
Not reported

New commitments and disbursements by fiscal year

Table 2.New commitments and disbursements by fiscal year (flows), US$ millions

FY2023-24US$ millions
New commitments0.1
DisbursementsNot reported
Cumulative disbursementsNot reported

Records and documents

Transactions1 transaction, January 1, 2024

Table 3.Transactions, US$ millions

DateMeasureAmountUS$ millionsSourceMethod
January 1, 2024Commitment0.1IATIincoming funds reported by the agency, provider as filed; country share applied
Terms5 of 6 reported
Finance type
110 Standard grant
Flow type
10 Official development assistance
Aid type
B03 Contributions to specific-purpose programs and funds managed by implementing partners
Tied status
5 Untied
Collaboration type
4 Multilateral outflows
Humanitarian
Not reported
Locations1 department
DepartmentsOuest
Places named by the sourceNot reported
Places with coordinates0

Partner documents

No document is listed for this operation.

Sources

Data as of October 20, 2026
SourceAccessed on
IATIOctober 20, 2026
Cite this page

HaitiDocs. Mitigate the risk of the emergence and re-emergence of high-threat pathogens. Partner portfolio, data as of October 20, 2026. https://www.haitidocs.org/portfolio/projects/UNFUND%3Acore%3AIATI%3AXM-DAC-928-HT-2024-25-02.002.AM01.HTI03